0000950123-18-008894.txt : 20180814
0000950123-18-008894.hdr.sgml : 20180814
20180814161254
ACCESSION NUMBER: 0000950123-18-008894
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180630
FILED AS OF DATE: 20180814
DATE AS OF CHANGE: 20180814
EFFECTIVENESS DATE: 20180814
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Pharmstandard International S.A.
CENTRAL INDEX KEY: 0001598762
IRS NUMBER: 000000000
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-17790
FILM NUMBER: 181017602
BUSINESS ADDRESS:
STREET 1: 10A, RUE HENRI SCHNADT
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2530
BUSINESS PHONE: 352 24840131
MAIL ADDRESS:
STREET 1: 10A, RUE HENRI SCHNADT
CITY: LUXEMBOURG
STATE: N4
ZIP: L-2530
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001598762
XXXXXXXX
06-30-2018
06-30-2018
Pharmstandard International S.A.
10a, rue Henri Schnadt
Luxembourg
N4
L-2530
13F HOLDINGS REPORT
028-17790
N
Eriks Martinovskis
Director
352 24840131
/s/ Eriks Martinovskis
Luxembourg
N4
08-14-2018
1
6
24931
false
1
Joint Stock Co Pharmstandard
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
Argos Therapeutics Inc.
Common
040221103
136
826153
SH
DFND
1
0
826153
0
Argos Therapeutics Inc.
Common
040221103
42
256030
SH
Call
DFND
1
0
256030
0
Proteon Therapeutics Inc.
Common
74371L109
3939
1607807
SH
DFND
1
0
1607807
0
Protagonist Therapeutics, Inc.
Common
74366E102
5044
750632
SH
DFND
1
0
750632
0
Jounce Therapeutics, Inc.
Common
481116101
4328
565063
SH
DFND
1
0
565063
0
Allena Pharmaceuticals
Common
018119107
11442
878131
SH
DFND
1
0
878131
0